From February 1 and October 28, 2020, the FDA used emergency authorizations to approve 289 in vitro diagnostic products, while using EUAs to approve five drug and biological products in the same time. This statistic illustrates the number of FDA emergency use authorizations (EUA) in the United States in the given period, by product type.
Number of FDA emergency authorizations between February and October 2020, by product type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
PwC. (December 16, 2020). Number of FDA emergency authorizations between February and October 2020, by product type [Graph]. In Statista. Retrieved August 08, 2022, from https://www.statista.com/statistics/1196001/fda-emergency-authorizations-number-by-type/
PwC. "Number of FDA emergency authorizations between February and October 2020, by product type." Chart. December 16, 2020. Statista. Accessed August 08, 2022. https://www.statista.com/statistics/1196001/fda-emergency-authorizations-number-by-type/
PwC. (2020). Number of FDA emergency authorizations between February and October 2020, by product type. Statista. Statista Inc.. Accessed: August 08, 2022. https://www.statista.com/statistics/1196001/fda-emergency-authorizations-number-by-type/
PwC. "Number of Fda Emergency Authorizations between February and October 2020, by Product Type." Statista, Statista Inc., 16 Dec 2020, https://www.statista.com/statistics/1196001/fda-emergency-authorizations-number-by-type/
PwC, Number of FDA emergency authorizations between February and October 2020, by product type Statista, https://www.statista.com/statistics/1196001/fda-emergency-authorizations-number-by-type/ (last visited August 08, 2022)
